Ultramicrosize Griseofulvin

NDC 0781-5827 · Sandoz Inc

Generic nameUltramicrosize Griseofulvin

Dosage formTABLET, COATED

RouteORAL

Active ingredient(s)GRISEOFULVIN

Strength125 mg/1

Pharmacologic classDecreased Mitosis [PE], Microtubule Inhibition [PE], Tubulin Inhibiting Agent [EPC]

Marketing categoryANDA

Packages

0781-5827-01 — 100 TABLET, COATED in 1 BOTTLE (0781-5827-01)

0781-5827-05 — 500 TABLET, COATED in 1 BOTTLE (0781-5827-05)

FDA lists these products with the same active ingredient.

0115-1724 — Ultramicrosize Griseofulvin Tablets, 0115-1725 — Ultramicrosize Griseofulvin Tablets, 0472-0013 — Griseofulvin, 0713-0850 — Griseofulvin, 0781-5514 — Griseofulvin, 0781-5515 — Griseofulvin, 0781-5828 — Ultramicrosize Griseofulvin, 23155-863 — Griseofulvin, 23155-864 — Griseofulvin, 23155-865 — griseofulvin, 42794-012 — Griseofulvin, 42794-013 — Ultramicrosize Griseofulvin, 42794-014 — Ultramicrosize Griseofulvin, 62135-494 — Griseofulvin, 62135-495 — Griseofulvin, 62135-496 — griseofulvin, 62135-501 — ULTRAMICROSIZE GRISEOFULVIN, 62135-968 — Griseofulvin (microsize), 69097-361 — grisofulvin, 73308-435 — ULTRAMICROSIZE GRISEOFULVIN

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.